Dolby Laboratories (DLB) Asset Writedowns and Impairment (2009 - 2026)

Dolby Laboratories has reported Asset Writedowns and Impairment for 18 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 134.36% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 47.98% YoY), and the FY2024 full-year result was -$2.3 million, down 113.9% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $2.9 million, up from $792000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $16.9 million in Q3 2023, with the low at -$2.6 million in Q3 2025.
• Historically, Asset Writedowns and Impairment has averaged $1.2 million across 5 years, with a median of $631000.0 in 2024.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment jumped 1132.34% — and 2025, when it slumped 2149.21%.
• Dolby Laboratories' Asset Writedowns and Impairment stood at -$1.0 million in 2022, then plunged by 103.98% to -$2.1 million in 2023, then jumped by 134.75% to $730000.0 in 2024, then grew by 8.49% to $792000.0 in 2025, then soared by 266.04% to $2.9 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $2.9 million (Q1 2026), $792000.0 (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.